These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25072620)

  • 1. Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults.
    Le Bourgeois A; Labopin M; Guillaume T; Delaunay J; Foucher Y; Tessoulin B; Malard F; Ayari S; Peterlin P; Derenne S; Herry P; Cesbron A; Gagne K; Lodé L; Illiaquer M; Imbert-Marcille BM; Le Gouill S; Moreau P; Mohty M; Chevallier P
    Exp Hematol; 2014 Nov; 42(11):945-54. PubMed ID: 25072620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults.
    Peterlin P; Delaunay J; Guillaume T; Gastinne T; Mahé B; Dubruille V; Blin N; Le Bourgeois A; Brissot E; Lodé L; Le Gouill S; Moreau P; Mohty M; Chevallier P
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):180-4. PubMed ID: 25175796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
    van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
    Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.
    Le Bourgeois A; Mohr C; Guillaume T; Delaunay J; Malard F; Loirat M; Peterlin P; Blin N; Dubruille V; Mahe B; Gastinne T; Le Gouill S; Moreau P; Mohty M; Planche L; Lode L; Bene MC; Chevallier P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):934-9. PubMed ID: 23523970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ABO blood group incompatibility on the outcome of single-unit cord blood transplantation after myeloablative conditioning.
    Konuma T; Kato S; Ooi J; Oiwa-Monna M; Ebihara Y; Mochizuki S; Yuji K; Ohno N; Kawamata T; Jo N; Yokoyama K; Uchimaru K; Tojo A; Takahashi S
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):577-81. PubMed ID: 24368297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].
    Bautista G; Regidor C; Gonzalo-Daganzo R; Cabrera JR
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():47-51. PubMed ID: 21381288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.
    Lister J; Gryn JF; McQueen KL; Harris DT; Rossetti JM; Shadduck RK
    Stem Cells Dev; 2007 Feb; 16(1):177-86. PubMed ID: 17348813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.
    Aoki J; Numata A; Yamamoto E; Fujii E; Tanaka M; Kanamori H
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2017-22. PubMed ID: 26226409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study.
    Dulery R; Salleron J; Dewilde A; Rossignol J; Boyle EM; Gay J; de Berranger E; Coiteux V; Jouet JP; Duhamel A; Yakoub-Agha I
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1080-9. PubMed ID: 22212513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation.
    Cirrone F; Ippoliti C; Wang H; Zhou XK; Gergis U; Mayer S; Shore T; van Besien K
    Leuk Lymphoma; 2016 Nov; 57(11):2555-9. PubMed ID: 26984480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation.
    Sanz J; Jaramillo FJ; Planelles D; Montesinos P; Lorenzo I; Moscardó F; Martin G; López F; Martínez J; Jarque I; de la Rubia J; Larrea L; Sanz MA; Sanz GF
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):106-10. PubMed ID: 24516896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complex relationship between human herpesvirus 6 and acute graft-versus-host disease.
    Pichereau C; Desseaux K; Janin A; Scieux C; Peffault de Latour R; Xhaard A; Robin M; Ribaud P; Agbalika F; Chevret S; Socié G
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):141-4. PubMed ID: 21801705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation.
    Baron F; Labopin M; Ruggeri A; Mohty M; Sanz G; Milpied N; Bacigalupo A; Rambaldi A; Bonifazi F; Bosi A; Sierra J; Yakoub-Agha I; Santasusana JM; Gluckman E; Nagler A
    J Hematol Oncol; 2015 Oct; 8():107. PubMed ID: 26445106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT).
    Cornetta K; Laughlin M; Carter S; Wall D; Weinthal J; Delaney C; Wagner J; Sweetman R; McCarthy P; Chao N
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):149-60. PubMed ID: 15682076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of CD8⁺ cell content on umbilical cord blood transplantation in adults with hematological malignancies.
    Moscardó F; Sanz J; Carbonell F; Sanz MA; Larrea L; Montesinos P; Lorenzo I; Vera B; Boluda B; Salazar C; Cañigral C; Planelles D; Jarque I; Solves P; Martín G; López F; de la Rubia J; Martínez J; Carpio N; Martínez-Cuadrón D; Puig N; Montoro JA; Roig R; Sanz GF
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1744-50. PubMed ID: 25008329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registry.
    Wallet HL; Sobh M; Morisset S; Robin M; Fegueux N; Fürst S; Mohty M; Deconinck E; Fouillard L; Bordigoni P; Rio B; Sirvent A; Renaud M; Dhedin N; Tabrizi R; Maury S; Buzyn A; Michel G; Maillard N; Cahn JY; Bay JO; Yakoub-Agha I; Huynh A; Schmidt-Tanguy A; Lamy T; Lioure B; Raus N; Marry E; Garnier F; Balère ML; Gluckman E; Rocha V; Socié G; Blaise D; Milpied N; Michallet M
    Exp Hematol; 2013 Nov; 41(11):924-33. PubMed ID: 23831606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
    Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
    Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for human herpesvirus 6 reactivation and its relationship with syndrome of inappropriate antidiuretic hormone secretion after stem cell transplantation in pediatric patients.
    Toriumi N; Kobayashi R; Yoshida M; Iguchi A; Sarashina T; Okubo H; Suzuki D; Sano H; Ogata M; Azuma H
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):379-83. PubMed ID: 23929317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.